An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab

  1. Sánchez Gomar, I.
  2. Díaz Sánchez, M.
  3. Uclés Sánchez, A.J.
  4. Casado Chocán, J.L.
  5. Ramírez-Lorca, R.
  6. Serna, A.
  7. Villadiego, J.
  8. Toledo-Aral, J.J.
  9. Echevarría, M.
Aldizkaria:
BMC Neurology

ISSN: 1471-2377

Argitalpen urtea: 2014

Alea: 14

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/1471-2377-14-139 GOOGLE SCHOLAR lock_openSarbide irekia editor